(Q34073047)
Statements
Interpretation of trailing endpoints in antifungal susceptibility testing by the National Committee for Clinical Laboratory Standards method (English)
S G Revankar
W R Kirkpatrick
R K McAtee
A W Fothergill
S W Redding
M G Rinaldi
1 January 1998